Thyroid hormone receptor beta (THRβ) is a key therapeutic target for metabolic dysfunction-associated steatotic liver disease and dyslipidemia, yet the discovery of structurally diverse agonists remains challenging. Here, we developed an AI-driven hierarchical drug discovery framework integrating graph neural network...
Shuai Han, Chao-Chun Wei, Han-Xue Ju et al.· Journal of Chemical Informat...· 0 citations
Ionization governs molecular behavior, yet predicting aqueous pKa accurately and tractably remains a fundamental challenge. Rigorous ensemble methods require enumerating a protonation-state space that grows exponentially with the number of ionizable sites, while fast graph predictors return numbers without thermodynami...
Zhuo-Yan Liu, Qiu-Yin Zhu, Qing-Kun Li et al.· bioRxiv· 0 citations
Transition state (TS) generation is typically evaluated by geometric similarity, yet low root-mean-square deviation (RMSD) does not establish first-order saddle-point character or reaction-path connectivity. Here we introduce Kairos-GFM, a deterministic equivariant flow-matching model that combines a two-dimensional re...
XSY12 is reported, a hydrophobic-tag degrader of the NSD3 PWWP domain that enables cellular NSD3 depletion and promotes proteasome-dependent NSD3 depletion accompanied by HSP90-associated signatures, reduces H3K36 methylation, and induces apoptosis and G2/M arrest in NSD3-dependent models.
Si-Yu Xiu, Zhenyu Jia, Qi Li et al.· Journal of Medicinal Chemist...· 0 citations
Generative artificial intelligence (AI) holds transformative potential for drug discovery, yet existing architectures typically operate in open loops without experimental feedback. Here we introduce rapid compound directed optimization (RCDO), a closed-loop reinforcement learning framework that accelerates the optimiza...
Han Wang, Dehua Lu, Weiping Lyu et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.